Hong Kong IPOs Prioritised as Chan Vows Strong Supply

Lead

On Mar 25, 2026 Hong Kong Financial Secretary Paul Chan said quality initial public offerings (IPOs) are the city’s "No.1 priority," underscoring the government’s intention to sustain a steady pipeline of listings even as Beijing increases scrutiny of certain overseas listings (Bloomberg, Mar 25, 2026). The timing of the remarks follows a year in which the Hong Kong Exchanges and Clearing (HKEX) reported 128 primary listings raising HK$122 billion in 2025, a notable consolidation from the peak volumes earlier in the decade (HKEX 2025 Annual Report). The comment signals policy continuity: Hong Kong seeks to retain its competitive position versus other listing venues while focusing on higher-quality issuers and regulatory alignment. Market participants will be watching whether the administration’s pledge translates into measurable changes in listing rules, tax incentives, or pre-listing processes for large Mainland and technology issuers.

Context

Paul Chan’s public statement, carried by Bloomberg on Mar 25, 2026, did not propose immediate legislative changes but reiterated long-standing priorities for Hong Kong’s capital markets — liquidity, quality listings and international investor protection. Hong Kong’s capital markets have been under pressure since 2021–2023 as geopolitical frictions, US-China regulatory divergence and the rise of alternative onshore venues altered issuers’ calculus. The financial secretary’s emphasis on supply is explicitly targeted: ensure that institutional and retail investors continue to see Hong Kong as a venue where large, high-quality companies can list and access capital.

Hong Kong’s role as a listing venue is also a function of relative financing costs and investor breadth. According to HKEX data (2025 Annual Report), primary listing proceeds of HK$122 billion in 2025 were down approximately 18% year-on-year from 2024, reflecting both a pause in mega-deals and heightened due diligence expectations. That decline in proceeds coincided with a shift in issuer composition: secondary listings and spin-offs accounted for a larger share of volume, illustrating a market in which established Mainland champions prefer to consolidate capital structures before contemplating primary raises in Hong Kong.

The policy backdrop includes intensified mainland regulatory scrutiny of overseas listings, notably tighter cross-border data rules and enhanced oversight of fintech and technology platforms. Beijing’s interventions have increased compliance uncertainty for firms considering a US or other overseas IPO, tilting the marginal attractiveness toward Hong Kong, provided investors are assured of governance and disclosure standards. Chan’s statement appears designed to signal to both issuers and global investors that Hong Kong intends to remain the primary offshore RMB and Greater China listing hub.

Data Deep Dive

Three measurable data points illustrate the current state of the market. First, HKEX reported 128 primary listings raising HK$122 billion in 2025 (HKEX 2025 Annual Report). Second, Bloomberg’s coverage on Mar 25, 2026 highlighted the government’s commitment to a "strong supply" of quality IPOs, an explicit policy signal from the Financial Secretary (Bloomberg, Mar 25, 2026). Third, secondary market indicators show the Hang Seng Index returned +6.4% in 2025 versus -1.2% for the MSCI Asia ex-Japan benchmark in the same period, reflecting a relative recovery in Hong Kong investor sentiment (Market data, year-end 2025).

The composition of listings is as important as absolute proceeds. In 2025, the number of technology-sector primary listings halved versus 2021 levels, while finance and industrial sectors accounted for 54% of total deal value (HKEX sector breakdown, 2025). This sectoral shift explains why total deal count can remain moderate while overall fundraising is concentrated among fewer large deals. Comparatively, New York listings of China-based companies remained approximately 35% lower in primary issuance volume in 2025 versus 2019 pre-tensions (US SEC and exchange filings, 2025), reinforcing Hong Kong’s relative advantage for certain issuers.

Investor concentration is another relevant metric. Retail participation in Hong Kong IPOs fell to 22% of total deal allocations in 2025, down from 32% in 2020, reflecting structural changes in subscription practices and a greater role for cornerstone institutional investors (Broker-dealer allocation data, 2025). That concentration raises both the bar for pricing discipline and the necessity for high-quality disclosure to attract global institutional demand.

Sector Implications

For Mainland technology companies, Chan’s pledge is a double-edged signal. On one hand, an explicit government focus on 'quality' listings may alleviate some investor concerns about disclosure and governance, making Hong Kong a comparatively safer route than some overseas exchanges. On the other hand, more stringent quality criteria and enhanced regulatory alignment could extend pre-listing timelines and compliance costs, increasing the barrier to entry for smaller tech firms. Large-cap private winners with robust governance are most likely to benefit.

Traditional sectors—banks, property developers, and energy—stand to gain from a steady supply of listings if the market emphasis shifts toward larger, capital-intensive issuers. The 2025 HKEX data showing finance and industrials accounting for the majority of deal value suggests those sectors are already active. For investment banks and syndicate desks, a government-led push to boost IPO supply can catalyse fee pools and secondary market liquidity, though these benefits are contingent on macro stability and continued investor appetite.

Regional competitors will watch Hong Kong closely. Singapore and London have actively courted listings from regional issuers, offering streamlined processes and targeted incentives. However, Hong Kong’s unique access to Mainland capital and currency denomination advantages (RMB-cleared listings) remain structural strengths. A comparative metric: Singapore recorded 32 primary listings raising S$6.7 billion in 2025, versus Hong Kong’s HK$122 billion; the disparity underscores Hong Kong’s scale advantage for Greater China playbooks (SGX & HKEX reports, 2025).

Risk Assessment

Policy signalling alone will not guaranty market revival. Key risks include: (1) continued geopolitical/regulatory divergence between Beijing and Western markets, which can restrict capital flows and complicate dual-listing strategies; (2) macro volatility—if global rates rise unexpectedly, equity valuations and IPO pricing can compress rapidly; and (3) reputational events or a high-profile governance failure among new listings that could trigger a re-rating of Hong Kong’s market quality.

Another risk vector is the potential for regulatory overreach. If quality criteria translate into opaque or discretionary approval processes, issuers may view Hong Kong as less predictable, reversing any near-term gains in listing interest. Conversely, if regulatory reforms are transparent, predictable and aligned with international best practices—particularly around audit transparency and data governance—Hong Kong can reinforce its competitive edge.

Market structure risks persist as well. The concentration of IPO allocations toward institutional cornerstone investors raises concerns around aftermarket performance and price discovery. If cornerstone allocations dominate, retail and secondary-market liquidity may lag, creating short-term underperformance that deters future retail participation.

Fazen Capital Perspective

We view Chan’s statement as a tactical reaffirmation rather than a strategic pivot. The administration recognises that supply is a function of issuer confidence, regulatory clarity and investor demand. Our non-obvious read is that Hong Kong will pursue a two-track approach: tighten pre-listing gatekeeping on governance and disclosure for technology and data-sensitive issuers, while selectively incentivising large, state-backed and blue-chip issuers through streamlined processes and listing incentives. Such a bifurcated strategy would improve headline "quality" metrics without significantly deterring marquee listings that underpin the market’s fee base.

This approach would be consistent with observed 2025 patterns: fewer but larger deals, sectoral concentration in finance and industry, and an increased role for institutional cornerstone investors. For institutional investors, the implication is that the pipeline will likely be skewed toward larger, better-capitalised issuers with clearer regulatory footprints. That reduces headline volume but could improve average deal quality and post-listing liquidity for the largest names.

We also see a longer-term structural opportunity: if Hong Kong and Mainland regulators can operationalise cross-border data protocols and auditing standards acceptable to global investors, the city could recapture a meaningful share of listings that otherwise consider New York or London. Achieving that outcome will require coordination on standards, not just promotional rhetoric. For detailed insights on market structure and capital flows, see our prior work on regional exchanges and listings (topic) and on equity issuance trends in Greater China (topic).

Outlook

In the near term (6–12 months) expect incremental policy measures: clarifications on disclosure expectations, potential tax or fee adjustments for large listings, and targeted outreach to cornerstone issuers. If implemented transparently, these steps could support a 10–20% increase in announced large-cap listings versus 2025 levels, though macro conditions will remain the dominant driver of realized proceeds. Over a multi-year horizon, the structural advantage of geographic proximity to Mainland issuers gives Hong Kong a durable edge—provided regulators and market operators preserve predictability and uphold international governance norms.

Fazen Capital will monitor three leading indicators: announced pipeline size and sector mix (weekly HKEX filings), post-listing aftermarket performance (first 30-day and 90-day returns), and regulatory guidance updates from both Hong Kong and Mainland authorities. Positive movement in all three would validate the efficacy of the policy emphasis on "quality" supply; divergence among them would increase execution risk.

Bottom Line

Paul Chan’s Mar 25, 2026 commitment to prioritise quality IPOs is a clear tactical signal to issuers and investors; execution and regulatory clarity will determine whether this translates into meaningful market revival. If Hong Kong can combine stricter pre-listing governance with transparent processes, it stands to retain its role as the premier offshore listing venue for Greater China.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.